Related references
Note: Only part of the references are listed.Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies
Laura M. Vos et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza
Timothy M. Uyeki et al.
CLINICAL INFECTIOUS DISEASES (2019)
Risk Factors for Influenza Virus Related Severe Lower Respiratory Tract Infection in Children
Aykut Eski et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes
Jeremy Katzen et al.
CLINICAL INFECTIOUS DISEASES (2019)
Impact of multiplex molecular assay turn-around-time on antibiotic utilization and clinical management of hospitalized children with acute respiratory tract infections
Brian R. Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness
Melissa A. Rolfes et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
Ryan E. Malosh et al.
VACCINE (2018)
Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015
Grace D. Appiah et al.
CLINICAL INFECTIOUS DISEASES (2017)
Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
Sudhir Venkatesan et al.
CLINICAL INFECTIOUS DISEASES (2017)
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
Joanna Dobson et al.
LANCET (2015)
The US Influenza Hospitalization Surveillance Network
Sandra S. Chaves et al.
EMERGING INFECTIOUS DISEASES (2015)
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial
Alicia M. Fry et al.
LANCET INFECTIOUS DISEASES (2014)
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
Stella G. Muthuri et al.
LANCET RESPIRATORY MEDICINE (2014)
Neuraminidase Inhibitors for Critically Ill Children With Influenza
Janice K. Louie et al.
PEDIATRICS (2013)
Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1) pdm09
Janice K. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Antiviral Treatment of Influenza in Children
Shikha Garg et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Risk Factors for Severe Illness with 2009 Pandemic Influenza A (H1N1) Virus Infection in China
Hongjie Yu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Oseltamivir Shortens Hospital Stays of Critically Ill Children Hospitalized With Seasonal Influenza A Retrospective Cohort Study
Susan E. Coffin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Alicia M. Siston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
Scott A. Harper et al.
CLINICAL INFECTIOUS DISEASES (2009)
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
Allison McGeer et al.
CLINICAL INFECTIOUS DISEASES (2007)
Early administration of oral oseltamivir increases the benefits of influenza treatment
FY Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)